Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB–IIIA non-small-cell lung cancer (Adjuvant Navelbine International …
…, JR Pereira, A Le Groumellec, V Lorusso… - The lancet …, 2006 - thelancet.com
Background Whether adjuvant chemotherapy improves survival of patients with non-small-cell
lung cancer (NSCLC) is not known. We aimed to compare the effect of adjuvant …
lung cancer (NSCLC) is not known. We aimed to compare the effect of adjuvant …
Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label …
D Cunningham, I Lang, E Marcuello, V Lorusso… - The lancet …, 2013 - thelancet.com
Background Elderly patients are often under-represented in clinical trials of metastatic colorectal
cancer. We aimed to assess the efficacy and safety of bevacizumab plus capecitabine …
cancer. We aimed to assess the efficacy and safety of bevacizumab plus capecitabine …
Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a …
…, S Ricci, G Gasparini, V Lorusso… - The lancet …, 2009 - thelancet.com
Background Clinical trials are needed to assess the clinical benefit of antithrombotic prophylaxis
in patients with cancer who are receiving chemotherapy, since these patients are at an …
in patients with cancer who are receiving chemotherapy, since these patients are at an …
Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non–small-cell lung cancer
G Frasci, V Lorusso, N Panza, P Comella… - Journal of Clinical …, 2000 - ascopubs.org
PURPOSE: To evaluate whether the addition of gemcitabine (G) to vinorelbine (V) improves
survival and quality of life (QoL) among elderly patients with advanced non–small-cell lung …
survival and quality of life (QoL) among elderly patients with advanced non–small-cell lung …
[HTML][HTML] Prevalence of malnutrition in patients at first medical oncology visit: the PreMiO study
M Muscaritoli, S Lucia, A Farcomeni, V Lorusso… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Background In cancer patients, malnutrition is associated with treatment toxicity, complications,
reduced physical functioning, and decreased survival. The Prevalence of Malnutrition in …
reduced physical functioning, and decreased survival. The Prevalence of Malnutrition in …
Gadolinium chelates with weak binding to serum proteins: a new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging
…, M DAPRA, LG IMPERATORI, V LORUSSO… - Investigative …, 1997 - journals.lww.com
RATIONALE AND OBJECTIVES The authors assess the effect of weak protein binding on the
efficacy of gadolinium chelates as contrast agents for magnetic resonance imaging (MRI). …
efficacy of gadolinium chelates as contrast agents for magnetic resonance imaging (MRI). …
Cytoskeleton and paclitaxel sensitivity in breast cancer: the role of β‐tubulins
…, N Kendzierski, A Latorre, V Lorusso… - … journal of cancer, 2007 - Wiley Online Library
The antineoplastic effect of paclitaxel is mainly related to its ability to bind the β subunit of
tubulin, thus preventing tubulin chain depolarization and inducing apoptosis. The relevance of …
tubulin, thus preventing tubulin chain depolarization and inducing apoptosis. The relevance of …
Safety, tolerance, biodistribution, and MR imaging enhancement of the liver with gadobenate dimeglumine: results of clinical pharmacologic and pilot imaging studies …
A Spinazzi, V Lorusso, G Pirovano, M Kirchin - Academic Radiology, 1999 - Elsevier
PURPOSE:: The purpose of this study was to assess safety, tolerance, biodistribution, and
magnetic resonance (MR) imaging enhancement of the liver with gadobenate dimeglumine. …
magnetic resonance (MR) imaging enhancement of the liver with gadobenate dimeglumine. …
Lapatinib/Paclitaxel polyelectrolyte nanocapsules for overcoming multidrug resistance in ovarian cancer
The sonication-assisted layer-by-layer (SLBL) technology was developed to combine necessary
factors for an efficient drug-delivery system: (i) control of nanocolloid size within 100 – …
factors for an efficient drug-delivery system: (i) control of nanocolloid size within 100 – …
Recombinant Apolipoprotein AIMilano Infusion Into Rabbit Carotid Artery Rapidly Removes Lipid From Fatty Streaks
…, P Lorenzon, M Laucello, V Lorusso… - Circulation …, 2002 - Am Heart Assoc
Apolipoprotein AI Milano (AIM), a natural variant of human apolipoprotein AI, confers to
carriers a significant protection against vascular disease. In previous studies, administration of …
carriers a significant protection against vascular disease. In previous studies, administration of …